Skip to content

DRI Amphetamine Assay

by Microgenics Corporation 3 variants

Ref 0018

DRI Amphetamine Assay (0018) is an amphetamine-specific IVD (EU IVDD general IVD; FDA Class II) made by Microgenics Corporation, registered in EUDAMED on 29 Dec 2025 (Basic UDI-DI B-00884883002821) and listed in FDA GUDID since 22 Sep 2016 (UDI-DI 00884883002821), active as of 22 Oct 2026.

Active European Union. Also listed in GUDID (US).

CE IVDD

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None, self-declared

Class I: no certifier involved

Trust

Unverified

Source EUDAMED, GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD EUDAMED NumberB-00884883002821 Basic UDI-DI 00884883002821UDI-DIDate29 Dec 2025RegisteredStatusActive
United StatesGUDID listing GUDID Number00884883002821 UDI-DI Date22 Sep 2016ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 30 May 2026, as the labeller entered it.

Across registries

2 registries list this device

  • EUDAMED Basic UDI-DI B-00884883002821 registered 29 Dec 2025 Active
  • FDA GUDID UDI-DI 00884883002821 listed 22 Sep 2016 Listed

Certificates

0 certificates · EUDAMED

No certifier certificate is listed. Devices of this class are self-declared by the manufacturer.

Timeline

2 dated events

  1. Listed FDA GUDID 00884883002821
  2. Registered EUDAMED B-00884883002821

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDD Active
  • United States GUDID listing Listed

Specification

EUDAMED · GUDID

Trade name
DRI Amphetamines Assay
Generic name
Amphetamine-specific IVD, kit, enzyme immunoassay (EIA)
Device name
DRI Amphetamine Assay
Model / reference
0018
Primary DI / UDI-DI
00884883002821
Basic UDI-DI
B-00884883002821
FDA product code
LAF, DKZ
EMDN code
W0102090101 Amphetamines group
GMDN term
Amphetamine-specific IVD, kit, enzyme immunoassay (EIA)
Device class
Class IVD General EUDAMED
Class II GUDID
Regulation number
862.3610, 862.3100
EU registration type
Legacy device (under a directive)
EU market of registration
Germany
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 1 field differs

FieldEUDAMEDGUDID
Device classEUDAMED
Class IVD General
GUDID
Class II

Device class is stated on each registry's own scale: Class IVD General in the EU (EUDAMED), Class II in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Manufacturer details

EUDAMED SRN
US-MF-000030375
Authorised representative
B·R·A·H·M·S GmbH DE-AR-000026031

Similar devices in this category

Other devices filed under AMPHETAMINES GROUP.

Other devices from Microgenics Corporation

See all devices from Microgenics Corporation →

Properties

  • Single use
  • Contains animal tissues or cells
  • Contains substances of microbial origin
  • Reagent
  • IVD kit
  • Professional testing
  • Lot / batch number
  • Expiration date
Other properties (18, all answered No)